TrialMedicine2020

Efficacy of DA-5204 (Stillen 2X) for patients with gastroesophageal reflux disease: A randomized, double-blind, placebo-controlled pilot study.

Jae Ho Cho et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.